Background Vitiligo is an acquired autoimmune skin disorder. The often-visible lesions of
vitiligo have a major impact on patients' quality of life and the results of the treatment …

Background The Janus kinase–signal transducer and activator of transcription signaling
pathway has been suggested as a promising therapeutic target in vitiligo. However, limited …

Background The Janus kinase-signal transducer and activator of transcription signaling
pathway has been suggested as a promising therapeutic target in vitiligo. However, limited …

Background Vitiligo is a chronic autoimmune disease in which the destruction of
melanocytes causes white spots on the affected skin. Janus kinase (JAK) is a family of …

Vitiligo is a common acquired depigmenting disorder characterized by the development of
white macules and patches due to the loss of melanocytes. Patients with vitiligo can be …

Janus kinases (JAKs) are non-receptor protein tyrosine kinases that are expressed in many
tissues. Once the JAKs are activated, a cascade of further signaling events is triggered …

Introduction Vitiligo is an autoimmune disorder which presents as depigmented macules
due to selective loss of melanocytes. Heightened expression of Janus Kinase Signal …

Vitiligo is a chronic autoimmune disease characterized by loss of pigment of the skin,
affecting 0.5–2% of the population worldwide. It can have a significant impact on patients' …

Vitiligo is an autoimmune pigmentary disorder characterized by depigmented patches of
skin with a selective loss of melanocytes. Recent advances describe vitiligo as a T-helper …

Vitiligo is a disease caused by the acquired depletion of melanocytes and/or melanocyte
precursor cells in response to genetic and environmental factors, resulting in …